ArticleCureus2023

Efficacy, Toxicity, and Prognostic Factors of Re-treatment With [177Lu]Lu-DOTA-TATE in Patients With Progressing Neuroendocrine Tumors: The Experience of a Single Center.

Maria Manuel Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.